# BROMFENAC SODIUM
> **ANDA204813** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-03-18
## Drug
- **FDA Application Number:** ANDA204813
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BROMFENAC SODIUM
- **Generic name:** BROMFENAC
- **Active ingredients:** BROMFENAC SODIUM
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2022-03-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204813)
---
*MORVS · CC0 1.0*